Sanders Reginald J. 4
4 · EyePoint Pharmaceuticals, Inc. · Filed Jan 8, 2025
Insider Transaction Report
Form 4
Sanders Reginald J.
Director
Transactions
- Award
Stock Options (Right to buy)
2025-01-08+80,000→ 80,000 totalExercise: $9.11Exp: 2035-01-08→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]The option becomes exercisable in three ratable annual installments beginning on January 8, 2026.